BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 32486841)

  • 1. Extract of
    Huang X; Chen Y; Zhang X; Li F; Ye H
    Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
    [No Abstract]   [Full Text] [Related]  

  • 2. miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway.
    Mao J; Hu X; Pang P; Zhou B; Li D; Shan H
    Oncol Rep; 2017 Jul; 38(1):393-401. PubMed ID: 28560434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling.
    Yang L; Xue H; Sun Y; Zhang L; Xue F; Ge R
    Cell Death Dis; 2020 Jul; 11(7):605. PubMed ID: 32732872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
    Li ML; Zhang Y; Ma LT
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
    Liu X; Wang S; Xu J; Kou B; Chen D; Wang Y; Zhu X
    BMC Complement Altern Med; 2018 Mar; 18(1):99. PubMed ID: 29554896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-515-5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway.
    Ni JS; Zheng H; Ou YL; Tao YP; Wang ZG; Song LH; Yan HL; Zhou WP
    Surg Oncol; 2020 Sep; 34():113-120. PubMed ID: 32891315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p.
    Wang ZY; Zhu Z; Wang HF; Qin B; Liu J; Yao XH; Li WC; Chen KS
    J Cell Physiol; 2019 Aug; 234(10):17775-17785. PubMed ID: 30864145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
    Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
    BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
    Ding H; Liu J; Zou R; Cheng P; Su Y
    J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-769-5p inhibits cancer progression in oral squamous cell carcinoma by directly targeting JAK1/STAT3 pathway.
    Zhou Y; Xu XM; Feng Y
    Neoplasma; 2020 May; 67(3):528-536. PubMed ID: 32064884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis.
    Zhao JA; Nie W; Dong L; Liu W; Wei W
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2967-2977. PubMed ID: 33982329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
    Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 19. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375.
    Li L; Xiao C; He K; Xiang G
    IUBMB Life; 2021 Sep; 73(9):1153-1165. PubMed ID: 34148288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between lncRNA DANCR and miR-125b-5p in HCC cell progression.
    Yang L; Jiang MN; Liu Y; Wu CQ; Liu H
    Tumori; 2021 Dec; 107(6):504-513. PubMed ID: 33272103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.